Entero Healthcare

What Entero Healthcare does

Entero Healthcare Solutions Limited is an Indian pharmaceutical and healthcare products distribution platform headquartered in Mumbai. The company serves two primary customer segments: 3,000+ hospitals through direct enterprise sales and 95,000+ retail pharmacies via its proprietary EnteroPreneur distribution network — a community-led, zero-investment partnership model in which local entrepreneurs onboard retailers, book orders through a mobile app, ensure last-mile delivery, and collect payments digitally. Its product portfolio spans 80,600+ SKUs across 2,000+ top pharmaceutical brands, distributed through a multi-tier channel architecture combining distributor partnerships, EnteroPreneur agents, and direct hospital sales teams.

The underlying technology stack consists of the EnteroPreneur mobile application (order booking, retailer onboarding, payment collection) and the HealthEdge retailer empowerment platform (flexible credit, transparent expiry returns, customer support). These platforms integrate with distributor inventory and supply chain systems to coordinate fulfilment. Supporting products include subsidiary operations in cardiology/medical devices (via Ace Cardiopathy Solutions, majority stake acquisition announced September 2025) and digital healthcare consumer services (via Aayu by MedCords, acquired March 2025).

Entero generates revenue through product margins on pharmaceutical and medical product sales (transaction-fee model). The company completed its IPO on Indian stock exchanges in April 2026 and reported Q4 FY26 revenue of ₹19.1 billion (43% YoY growth) with EBITDA of ₹0.9 billion (76% YoY growth). Recent strategic activity includes the divestment of Suprabhat Pharmaceutical and the majority acquisition of Ace Cardiopathy Solutions, signaling portfolio reshaping toward higher-value specialty healthcare verticals. Domestic institutional investors increased their stake by 6.8 percentage points in Q3FY26, and brokerages (Jefferies, YES Securities) maintain Buy ratings with implied 17-21% upside.

Name

Entero Healthcare

Legal name

Entero Healthcare Solutions Limited

Website

https://enterohealthcare.com

Company type

Public

Founded year

2018

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Entero Healthcare Solutions is an Indian pharmaceutical and healthcare products distribution platform serving 3,000+ hospitals and 95,000+ retail pharmacies through its EnteroPreneur zero-investment partner network, distributing 80,600+ SKUs across 2,000+ brands.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

akta.pro secondary industry

Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)

Keywords

• Pharmaceutical distribution
• Healthcare supply chain
• Medical product distribution
• Pharma distribution network
• Hospital pharmacy supply

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Distribution: Revenue generated from distributing pharmaceutical and medical products to hospitals and retail pharmacies across India. The company operates with a wide portfolio of 80,600+ SKUs across 2,000+ brands, generating revenue through product margins on sales to healthcare providers.
2. EnteroPreneur Network: Revenue model involving zero-investment franchise partners who facilitate last-mile distribution. EnteroPreneurs generate income by booking orders and ensuring delivery, with potential revenue of ₹15-75 Thousands monthly based on scale.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Entero Healthcare distributes pharmaceutical and medical products across India through a tech-enabled supply chain platform. It sells a portfolio of 80,600+ SKUs from 2,000+ top pharma brands to 3,000+ hospitals and 95,000+ retail pharmacies, using the EnteroPreneur zero-investment partner program for last-mile delivery and the HealthEdge platform for retailer empowerment.

Product overview

Entero Healthcare is one of India's largest healthcare products distribution platforms. The company operates primarily through its EnteroPreneur program—a zero-investment partnership model that connects pharmaceutical distributors, EnteroPreneurs (local agents), and retailers via a technology-enabled app. The platform offers access to 80,600+ SKUs across 2,000+ top pharma brands, serving 3,000+ hospitals and 95,000+ retailers. The subsidiary platform HealthEdge provides retailer empowerment services including flexible credit and inventory management.

Differentiator

Problem solved

Functional benefit

Brands

• EnteroPreneur: A partner program enabling individuals to join as EnteroPreneurs to distribute pharmaceutical products, offering zero investment opportunity with earning potential

Products and services

• EnteroPreneur Partner Program

Quantifiable outcome

• 43% YoY revenue growth in Q4 FY26 to ₹19.1 billion
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Ace Cardiopathy SolutionscoreStrategic or Co-development Partner · 29 September 2025Entero Healthcare acquired a majority stake in Ace Cardiopathy Solutions for INR 59.30-77.10 crore, expected to complete by early 2026. This acquisition expands Entero's presence in the cardiology/medical devices segment, complementing its existing pharmaceutical distribution business.
• Suprabhat PharmaceuticalminorStrategic or Co-development Partner · 29 September 2025Entero Healthcare divested its stake in Suprabhat Pharmaceutical for up to INR 37 lakhs as part of portfolio reshaping strategy. This divestment reflects the company's focus on higher-value partnerships and acquisitions.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Medplus Health Services: One of India's largest retail pharmacy chains with 4,000+ stores, operating a vertically integrated pharma distribution model that supplies its own retail network — closely comparable to Entero's hospital and retailer distribution operations in the Indian market.
• Apollo Pharmacy: Retail pharmacy arm of Apollo Hospitals with thousands of outlets across India, combining direct distribution with hospital pharmacy operations — directly comparable to Entero's hospital + retailer distribution footprint.

Emerging players

• Tata 1mg: Digital health and online pharmacy platform backed by Tata, competing in pharma distribution via direct-to-consumer delivery — represents the digital disruption threat to Entero's traditional retailer-led distribution model.
• PharmEasy: Leading Indian online pharmacy and diagnostic aggregator offering medicine delivery directly to consumers, bypassing traditional retailers — a key competitive threat to Entero's 95,000+ retailer network.
• Netmeds: Online pharmacy platform acquired by Reliance, offering prescription and OTC medicine delivery across India — competes with Entero's distribution model via direct-to-consumer digital channel.

Broad incumbents

• Cipla: One of India's largest pharmaceutical manufacturers with substantial distribution operations — represents the broader incumbent landscape Entero competes against for hospital and retailer supply contracts.
• Sun Pharmaceutical Industries: India's largest pharma company by revenue with extensive domestic distribution infrastructure — comparable as a large incumbent pharma player with significant wholesaling capability.
• Mankind Pharma: Top-five Indian pharma company with strong OTC and prescription distribution — competes with Entero for shelf space at retail pharmacies and hospital supply contracts.
• Alkem Laboratories: Major Indian pharma manufacturer with established pan-India distribution — comparable as a broad incumbent player with overlapping hospital and retailer channels.

Regional players

• Zota Healthcare: Indian pharma distribution and retail company with a more regional focus — comparable business model (wholesale + retail pharmacy) at smaller scale, useful as a regional benchmark.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Entero Healthcare